SAB Biotherapeutics Cash Flow Statement (2020-2025) | SABS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income 1.41M-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-9.94M-10.78M-9.78M-12.07M
Share-based Compensation 0.35M0.43M0.88M0.65M0.90M0.57M0.58M0.63M0.60M0.64M0.64M1.99M0.62M0.60M1.05M0.67M0.61M0.63M0.80M
Gains from Sales and Divestitures 0.07M0.11M0.01M0.02M0.03M0.03M0.02M0.00M0.01M0.01M
Gains from Investment Securities 4.10M0.05M1.95M3.89M-7.85M-1.73M-0.78M-0.04M-0.08M0.36M4.73M2.07M-2.22M-0.01M2.31M2.96M2.94M6.75M
Non-cash Items 28.90M10.50M5.20M5.10M0.11M4.50M4.20M3.60M0.66M6.80M5.20M6.90M6.30M5.70M5.20M11.80M
Change in Interest Receivables 0.19M0.03M-0.13M-0.04M-0.03M-0.02M0.56M
Cash from Operations -0.01M9.45M-6.39M3.80M-4.88M-9.54M-4.45M-7.92M-1.56M-1.61M-4.90M-5.17M-13.45M-10.75M-7.72M-6.29M-9.53M-7.80M-7.15M-13.05M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.04M0.04M0.04M0.04M0.04M0.03M0.02M0.02M0.03M0.02M0.02M0.03M0.08M0.02M0.02M0.02M0.02M0.02M0.02M
Amortization of Deferred Charges 0.04M0.04M0.04M0.04M0.04M0.03M0.02M
Depreciation & Amortization (CF) 0.24M0.26M0.37M0.62M0.64M0.75M0.89M0.93M0.90M0.90M1.00M0.97M2.00M1.00M0.90M0.76M0.80M0.80M0.70M
Change in Working Capital
Change in Receivables -8.98M5.52M-6.90M-2.20M3.78M-2.17M3.33M-7.39M-4.79M-0.40M-0.36M
Change in Account Payables -3.84M1.96M-1.40M0.34M0.52M-0.04M0.54M-1.81M-2.23M-0.04M-0.32M-0.11M0.24M-0.05M0.13M0.59M0.68M0.14M0.34M
Change in Accured Expenses 0.00M2.97M-1.44M1.58M0.28M-0.60M-2.00M0.38M-0.32M-1.73M-0.76M-0.63M1.40M-1.58M-0.07M1.86M-1.44M0.58M1.04M-0.29M
Change in Taxes 0.09M
Investing Activities
Capital Expenditures 1.89M3.46M3.23M2.36M1.36M0.61M0.08M0.12M0.02M0.02M0.09M0.07M0.13M0.05M0.10M0.06M
Sales of Property, Plant and Equipment 0.08M0.04M500.00
Change in Acquisitions & Divestments 3.75M10.69M4.74M5.25M
Cash from Investing Activities -1.89M-3.46M-3.23M-2.36M-1.28M-0.61M-0.08M-0.12M-0.02M-0.02M-0.04M-0.07M-31.36M11.22M-1.15M9.33M4.67M5.20M-129.87M
Financing Activities
Other financing activities 0.08M0.35M-0.14M-0.20M0.01M0.07M0.00M0.00M0.02M0.00M0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances 0.15M0.15M
Long-Term Debt Repayments 0.76M0.76M0.25M0.49M0.33M0.33M0.11M0.26M0.22M0.22M0.62M0.24M0.14M0.14M3.00
Change in Capital Stock
Shares Issued 0.03M4.17M-4.17M0.01M0.07M1.007.60M0.00M0.00M59.65M0.02M-3.00
Misc.
Cash from Financing Activities 0.09M-0.05M-0.05M-0.05M36.03M-6.32M-0.73M-0.29M8.39M-0.36M-0.36M-0.14M67.64M-0.39M-0.32M-0.67M0.22M-0.17M-0.17M168.69M
Exchange Rate Effect -0.03M0.03M0.05M-0.29M0.04M0.18M-0.04M
Change in Cash 0.08M7.52M-9.90M0.52M28.79M-17.14M-5.79M-8.28M6.71M-1.99M-5.29M-5.35M54.14M-42.53M3.21M-8.07M-0.27M-3.26M-1.95M25.73M
Beginning Cash Balance 12.53M12.61M20.13M10.23M4.41M39.55M22.41M16.62M8.33M15.05M13.06M7.77M2.43M56.57M14.03M17.27M9.17M8.90M5.64M3.69M
Free Cash Flow -0.01M7.56M-9.85M0.57M-7.24M-10.90M-5.06M-8.00M-1.67M-1.63M-4.92M-5.25M-13.51M-10.88M-7.77M-6.39M-9.59M-7.80M-7.15M-13.05M
Net Cash Flow 0.08M7.52M-9.90M0.52M28.79M-17.14M-5.79M-8.28M6.71M-1.99M-5.29M-5.35M54.12M-42.50M3.18M-8.12M0.02M-3.30M-2.13M25.77M